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1. Introduction 
Electrophoretic methods compose a family of related techniques that use narrow-bore fused-
silica capillaries to perform high efficiency separations of both small and large molecules. 
These methods are commonly known as capillary electrophoretic methods. Capillary 
electrophoresis (CE) has, over the years, demonstrated its powerful separation ability in the 
area of chiral and achiral analysis. This is contributed to the advantages it offers when 
compared to chromatographic techniques: (1) low consumption of samples and solvents; (2) 
high separation efficiency and resolution; (3) versatility [1,2]. 
Two of the most important modes of CE, which will be discussed in this chapter, are 
capillary zone electrophoresis (CZE) and micellar electrokinetic chromatography (MEKC). 
CZE is the simplest and the most widely used mode of CE [1]. The separation mechanism of 
the analytes is based on their difference in charge-to-size ratios and their difference in 
electrophoretic mobilities, which, in turn, result in different velocities. However, due to the 
fact that neutral species do not possess an electrophoretic mobility, they cannot be separated 
by use of this mode. 
In order to circumvent this problem, new modes of CE have been suggested as alternatives. 
MEKC, which combines the best features of both electrophoresis and chromatography, is 
considered an alternative mode because it can be used for the separation of charged as well 
as neutral compounds. It involves the introduction of a surfactant at a concentration above 
the critical micellar concentration (CMC), at which micelles are formed. MEKC was first 
introduced by Terabe et al. in 1984 [3]. Although it is a form of CE, its separation principle is 
more similar to HPLC than to CE. In this mode, analytes are separated according to their 
partitioning between the mobile and stationary phase and, when charged, their 
electrophoretic mobility. The driving force for the partitioning of analytes is hydrophobicity. 
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In addition, hydrogen bonding, dipole-dipole, and dispersive interactions can contribute to 
the solute partitioning between the two phases [4-6]. 
CE was originally considered as a powerful analytical tool for the analysis of biological 
macromolecules. It has though, over the years, been extensively used for the separation of 
other compounds, such as chiral drugs, food additives, pesticides, inorganic ions, organic 
acids, and others. In this chapter, the ability of CE, and particularly CZE and MEKC, to be 
used for the qualitative and quantitative determination of compounds in pharmaceutical, 
biological and natural samples is investigated. In each approach, a number of studies are 
reported and discussed. These studies involve establishment of optimum separation 
conditions, method validation, optimization of sample-preparation procedure and 
application for the determination of the analytes under study in real samples. The first part 
of this chapter involves the determination of polyphenolic compounds using CZE with UV-
Vis detector in red and white wines, while the second part involves the determination of 
pharmaceutical compounds in biological samples, such as blood and urine, using the 
hyphenated technique CE-MS (mass spectrometry). The third and final part emphasizes the 
importance of MEKC in chiral analysis since it has been known that usually only one 
enantiomer is active, while the other may be less active, inactive or has adverse effects. 
2. Determination of polyphenolic compounds in natural samples 
Polyphenolic compounds exist in a variety of natural products, such as fruits, vegetables, 
beverages (tea, wine and juices), honey, cacao and herbs. They attract a lot of interest due to 
their beneficial implication in human health. They have been widely studied due to their 
antioxidant capacity and their association with several pathological conditions, such as 
hypertension, cardiovascular disease, dementia, and even cancer [7-9]. Therefore, due to 
their health significance, numerous analytical methods have, over the last decades, been 
developed for their separation, identification and quantitation in natural products [10-13]. 
According to literature, the simplest CE method, CZE, proved to be the best method for the 
determination of polyphenolic compounds in wine samples [14-17]. In such studies, and in 
each case, when the optimum CZE method was applied to different red and white wines, it 
was established that red wines have higher levels of polyphenolic compounds than white 
wines and that the polyphenolic composition varies among different wines. 
2.1. Method development and validation 
In this part of the chapter, a representative study performed recently in Cypriot wines is 
briefly described [17]. The influence of several experimental parameters is initially 
illustrated in order to obtain improved selectivity and resolution for the separation of seven 
flavonoids, which constitute the most important group of polyphenols, and trans-rasveratrol 
that are usually present in wine. This is accomplished by use of CZE and by examining 
different sample preparation procedures. Due to the low concentrations of flavonoids in 
wine and the high complexity of wine matrices, preconcentration methods are required, 
which can simplify the electropherograms. The optimized CZE and pre-treatment methods 
proved to be effective in characterizing flavonoids in red and white wine samples. 
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The effect of column temperature, and concentration and pH of background electrolyte 
(BGE) were investigated. These parameters, along with the applied voltage, are the most 
common parameters that are required to be examined in order to optimize a separation  
in CZE. Figure 1 illustrates the influence of the pH on the resolution and the analysis time.   
 
 
 
Figure 1. Effect of pH value on the separation of the eight polyphenols. (A) pH 9; (B) pH 9.3; (C) pH 9.6. 
Conditions: BGE 50 mM borate, 10 mM phosphate and 20 mM SDS; pressure injection, 30 mbar for 3 
sec; applied voltage, 25 kV; temperature, 25 ºC; fused-silica capillary, 64 cm (55.5 cm effective length) x 
50 μm i.d.; detection, 205 nm. Peak identification: trans-resveratrol (1), epicatechin (2), catechin (3), 
naringenin (4), kaempferol (5), apigenin (6), myricetin (7), quercetin (8) [17]. 
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The last two increased with increasing the pH, possibly due to an increase in the negative 
charge, which resulted in a greater affinity and a higher complexation between borate and 
phenols. Taking into consideration the migration times, the peak efficiency and the 
sufficient resolution, the following parameters provided a baseline separation of all 
polyphenolic compounds: BGE containing 50 mM borate and 10 mM phosphate at pH 9.6 
and column temperature of 25 ºC (Figure 1C). The use of alkaline borate-based BGEs, in 
CZE, resulted in a sufficient separation of polyphenols due to the complex-formation ability 
of borate. In addition, an increase in the borate concentration from 25 to 50 mM and an 
increase in the pH value from 9 to 10 resulted in an increase in the migration times of all 
analytes, while the resolution was significantly improved. At pH 10 though, the analysis 
time was very long (~ 50 min) and joule heating effects, such as high current generation and 
peak broadering, were observed. An increase in pH increased the negative charge of the 
analytes, which, in turn, favored a greater affinity for the buffer and a higher complexation 
between borate and phenols [18]. 
The method was then validated by the terms of linearity, precision and LOD. Linearities for 
the eight analytes were very good, and precision, which was based on the relative standard 
deviation, was below 1%, indicating an excellent reproducibility. In addition, LODs, which 
were calculated as three times the standard deviation via the slope of the calibration curve, 
were between 0.03 and 5.05 μg/mL for all eight polyphenolic compounds. 
2.2. Application 
The qualitative and quantitative analysis of analytes in real samples is often difficult due to 
interruptions caused by different interfering substances found in the sample matrix. 
Therefore, a sample-preparation procedure is a necessary step prior to the electrophoretic 
analysis, in order to isolate the analytes under study from real samples. Different 
preconcentration methods have been used over the years, including solid-phase extraction 
(SPE) with C-18, silica, or other cartridges [14,16,19] and liquid-liquid extraction (LLE) with 
different organic solvents [10,20,21]. 
In the study performed in Cypriot wines, the sample preparation procedure was optimized 
in order to determine the one that was simple, fast and reliable [17]. Therefore, three LLE-
procedures (C,D,E), a SPE-procedure (F), a procedure that involve evaporation and 
reconstitution of wine sample (B) and a direct injection of wine sample after dilution and 
filtration (A) were compared and the most effective method was applied to Cypriot wines. 
The electropherograms obtained by use of each sample preparation procedure are 
illustrated in Figure 2. When no extraction was performed, the electropherograms were 
complex, while SPE was found to be ineffective for the isolation of polyphenolic compounds 
from wine samples. LLE with diethyl ether, followed by evaporation of organic layer by 
nitrogen stream and reconstitution in ethanol proved to be the optimum sample pre-
treatment method. When the optimum method was applied to Cypriot wine samples, the 
quantification of polyphenolic compounds was successfully achieved. It was observed that 
epicatechin and catechin exist in all wine samples in comparable concentrations, whereas 
myricetin and quercetin exist only in two of the three wine samples. Polyphenolic 
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composition varies among different wines, because it depends on several factors, such as the 
type of grapes used, the vivification process used, the type of yeast that participates in the 
fermentation, weather variations and other biological effects [22]. 
 
 
Figure 2. Electropherograms of the wine samples obtained using six different sample preparation 
procedures under optimum conditions. Conditions: BGE 50 mM borate, 10 mM phosphate and 20 mM 
SDS (pH 9.6); pressure injection, 30 mbar for 3 sec; applied voltage, 25 kV; temperature, 25 ºC; fused-
silica capillary, 64 cm (55.5 cm effective length) x 50 μm i.d.; detection, 205 nm. Peak identification: 
epicatechin (2), catechin (3), myricetin (7), quercetin (8) [17]. 
Another important observation was that in white wine, the only flavonoid that was detected 
was catechin at a concentration of 7.3 μg/mL. This was not surprising since the majority of 
flavonoids in wine come from the extraction derived from grape’s solids. White wine is 
made by pressing the juice away from the grape’s solids, and then, by allowing it to ferment. 
So, red wines have higher levels of polyphenolic compounds [23]. 
3. Determination of pharmaceutical compounds in biological samples 
Quantification of drugs in biological fluids, like plasma, has an important role in drug 
discovery and development. There are two main aspects that are taken into account in order 
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to make the identification of drugs in biological fluids possible. The first aspect is the 
development of an accurate analytical method, with high sensitivity, capable to identify 
desirable compounds in concentrations comparable to that in biological fluids. The second 
one is the exploration of the optimum extraction method that can effectively extract the drug 
from the biological matrix. 
Over the years, CE coupled to electrospray ionization-mass spectrometry (ESI-MS) has been 
utilized as a bioanalytical tool for the analysis of drug compounds in biological samples [24-
29]. Even though the most common detector in CE is the UV detector due to its easy 
manageability and low cost, it has the drawback of low sensitivity due to the short optical 
path length. An alternative to this is the use of MS. The coupling of CE with MS is a well-
established technique, which combines the high efficiency and resolution that are provided 
by CE and the detection sensitivity and selectivity and the identification potential that are 
provided by MS [25,30].  
In recent years, a large number of publications have been provided on the general 
developments and biological applications of CE-ESI-MS [24-29]. Zheng et al. developed a 
CZE-ESI-MS method for monitoring the antiepileptic drug lamotrigine in human plasma 
[27]. The optimum conditions were obtained by varying a big number of BGE, sheath liquid 
and MS spray chamber parameters. In each case, both the CZE separation, as well as the MS 
detection sensitivity, were evaluated, and the parameter that provided a reasonable 
compromise between resolution and detection sensitivity was chosen as the optimum. The 
developed method was then applied to assay blank samples spiked with lamotrigine in 
order to set up the calibration curve and estimate the limit of detection (LOD). Both linearity 
of calibration curve and LOD (0.05 μg/mL) were good, and the optimum method was 
applied to 14 human plasma samples collected from a lamotrigine-treated subject over a 
period of 96 h after oral administration of 50 mg lamotrigine. 
In a 2011 study, Elhamili et al. analyzed the anticancer drug Imatinib by use of CE coupled 
to ESI time-of-flight MS in human plasma [29]. The CE separation and ESI parameters were 
initially investigated and optimized in regard to peak efficiency, peak intensity and 
electrospray stability. The LOD and limit of quantitation (LOQ) were evaluated by injections 
of standard solutions of the drug compound, and they were determined to 5 and 20 ng/mL, 
respectively. In addition, the extraction recovery of Imatinib from human plasma using a 
common liquid-liquid extraction (LLE) method and a new strong cation exchange (SCX) 
solid-phase extraction (SPE) column was investigated and compared. The highest extraction 
recoveries were obtained by using the latter method. The SCX-SPE extraction followed by 
CE-ESI-TOF-MS analysis in patient plasma samples demonstrated good repeatability, 
linearity and sensitivity for possible therapeutic monitoring of Imatinib level. The authors, 
in this manuscript, also conclude that this method could be applied for the analysis, 
quantification, and clinical assessment of other drug compounds and their metabolites. 
3.1. Method development 
The performance and usefulness of CE-MS is also demonstrated here by providing a more 
in-depth analysis of a research work that was performed in a blood sample obtained from a 
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patient with Alzheimer´s Disease (AD) [24]. In this study, a CZE-ESI-MS method was 
developed for the analysis of the acetylcholinesterase inhibitor rivastigmine, using 
neostigmine bromide as an internal standard, which is highly recommended in order to 
avoid problems that are related to sample injection [31]. Rivastigmine is a pseudo-
irreversible carbamate inhibitor of acetylcholinesterase, and it is clinically used for the 
symptomatic treatment of mild to moderate AD [32]. 
In a previous paper, MEKC coupled to a diode-array detector was used for the simultaneous 
separation of nine acetylcholinesterase inhibitors, including rivastigmine [33]. This method 
was validated and successfully applied to a real blood sample that was obtained from a patient 
who was not under any of this medication. The sample was spiked with rivastigmine in order 
to establish the ability of the method to separate the drug from other components that might 
exist in the blood sample. In this study, the blood sample was not directly injected into the 
capillary, because some components that exist in the sample can be absorbed to the capillary 
wall and deteriorate the performance of the column [34]. The blood sample was therefore 
diluted ten folds with the BGE [12.5 mM Na2HPO4 / 12.5 mM Na2B4O7 / 20 mM SDS (pH 10)], 
and it was then spiked with 25 μg/mL of rivastigmine. However, due to the low sensitivity 
obtained by CE with on-column UV detection, the identification of rivastigmine in biological 
fluids using CE remained a challenge. In order for the technique to be used for the quantitation 
of an acetylcholinesterase inhibitor in body fluids, the sensitivity, and consequently the LOD 
had to be improved. The increased interest in exploring CE-MS and its potential to serve as an 
alternative method allowed further investigation for the determination of rivastigmine and 
related drugs in complex biological matrices. 
When the CZE-UV method was compared with the CZE-MS, the first demonstrated a 
shorter analysis time of approximately 2 min due to the shorter effective length, while the 
S/N for the peak of rivastigmine at the SIM mode was estimated to be eight times bigger 
than with UV detection. This, in turn, indicated the high specificity and selectivity of the 
ESI-MS detector [24]. In the CZE-ESI-MS study, several electrophoretic and ESI-MS 
parameters were also examined, which were classified in three categories: the BGE 
parameters, such as the concentration, the pH and the use of organic modifier, sheath liquid 
parameters, such as the composition, the methanol (MeOH) content and the flow rate, and 
finally some spray chamber parameters, such as the temperature and the flow rate of the 
drying gas and the nebulizer gas pressure. The effect of each parameter on the S/N, and 
consequently the LOD, was examined and the optimum one was chosen for further 
optimization. 
In the case of BGE parameters, it was observed that ammonium acetate provided the most 
reproducible migration times, a concentration of 40 mM ammonium acetate resulted in the 
highest S/N, while a higher concentration decreased the ratio, probably due to the Joule 
heating effect that increases the level of noise (Figures 3a & 4a). When the pH was 
examined, it was concluded that at pH 9, where rivastigmine starts to have a negative 
charge (pKa=8.6), both the analysis time and resolution increased, and a higher S/N was 
obtained (Figures 3b & 4b). 
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Figure 3. Effect of (a) ionic strength and (b) pH of the BGE on the separation of rivastigmine (2) and I.S 
(1). Conditions: BGE: ammonium acetate, sheath liquid 1 % acetic acid in water:MeOH (50:50 v/v) at a 
flow rate of 10 μL/min, analyte and I.S. concentrations 0.3 mg/mL. Drying gas flow rate 6 L/min and 
temperature 200 ºC, nebulizer gas pressure 20 psi [24]. 
 
Figure 4. Effect of (a) ionic strength of the BGE and (b) pH of the BGE upon S/N ratio. Conditions: BGE: 
ammonium acetate, sheath liquid 1 % acetic acid in water:MeOH (50:50 v/v) at a flow rate of 10 μL/min, 
analyte and I.S. concentrations 0.3 mg/mL. Drying gas flow rate 6 L/min and temperature 200 ºC, 
nebulizer gas pressure 20 psi [24]. 
As far as the sheath liquid parameters are concerned, it was observed that its composition 
and its flow rate affected the ESI-MS sensitivity significantly. This was not a surprising 
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observation since the sheath liquid plays an important role in the CE-MS system. The sheath 
liquid is used as the make-up liquid that can solve the flow-rate incompatibility problems 
between CE and MS [35]. These problems are encountered because the flow rate through the 
CE column is very low (nL/min), and it cannot support a stable electrospray, whose flow 
rate is typically a few μL/min. In addition, the sheath liquid is used for establishing an 
electrical connection at the cathode end of the CE capillary, and it provides the suitable 
solvent conditions for the electrospray, which does not depend on the CE BGE [36]. 
When different sheath liquids were evaluated, the one that was able to support the 
formation of positively charged ions, and consequently provide the highest S/N, was acetic 
acid (1%) (Figure 5a). The influence of methanol as an organic modifier in the sheath liquid 
was also examined, because the use of such solvents allows an easier protonation of the 
analytes, which results in a higher signal [28]. By varying the percentage of methanol, it was 
concluded that 50% was the optimum since the noise level was the lowest (Figure 5b). 
Finally, the flow rate of the sheath liquid was set at 10 μL/min (Figure 5c). Other values 
were either too low to establish an electric contact that is required to achieve separation, or 
they affected the spray stability negatively, which, in turn, lead to higher noise levels. 
 
 
Figure 5. Effect of (a) sheath liquid composition, (b) sheath liquid organic modifier and (c) sheath liquid 
flow rate upon S/N ratio. Conditions: BGE: ammonium acetate 40 mM, at pH 9.0; analyte and I.S. 
concentrations 0.3 mg/mL. Drying gas flow rate 6 L/min and temperature 200 ºC, nebulizer gas pressure 
20 psi [24]. 
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The spray chamber parameters, which are the last parameters examined in this study, have 
an important effect on the response of the MS system. One of these parameters involves the 
drying gas, which is used for accelerating the buffer desolvation, increasing the MS 
sensitivity, and eliminating any undesirable ions from entering into the MS system. It was 
observed that the drying gas flow rate has an effect on the stability of the electrospray, and 
consequently, the levels of the noise. The flow rate was set at 6 L/min, because at this flow 
rate an increased number of ions come closer to the liquid-gas interface, and this increases 
the desolvation velocity [37] (Figure 6a). In addition, other flow rates that were examined in 
this study either caused an unstable electrospray or lowered the S/N. The drying gas 
temperature was varied from 150 °C to 350 °C, and the highest S/N was obtained at 200 °C, 
which was considered as the optimum (Figure 6b). The nebulizer gas pressure was the last 
parameter examined in this category, and based on the stability of the electrospray and the 
S/N, 20 psi was selected as the optimum. At 20 psi, the electrospray is more efficient, 
probably due to an improved ion evaporation process because smaller initial droplets are 
obtained with higher nebulizer gas pressure (Figure 6c). 
 
 
 
 
Figure 6. Effect of (a) drying gas flow rate, (b) drying gas temperature and (c) nebulizer gas pressure 
upon S/N ratio. Conditions: BGE: ammonium acetate 40 mM at pH 9.0, sheath liquid 1 % acetic acid in 
water:MeOH (50:50 v/v) at a flow rate of 10 μL/min, analyte and I.S. concentrations 0.3 mg/mL [24]. 
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3.2. Method validation 
All the parameters mentioned above are the common parameters that need to be examined 
in a method development process that involves a CE-MS system. These parameters affect 
the analysis time, resolution, response of the analyte under study, noise level, and 
sensitivity of the system. All these are important if the developed method is expected to be 
applied to biological samples for the detection and the quantification of drug and other 
compounds. 
When the optimum conditions for the analysis of rivastigmine were determined, the method 
was validated in terms of linearity, precision, stability, recovery, LOD and LOQ. Two 
calibration curves were constructed, in human plasma and in standard solutions, and 
linearity was good in both cases. The precision, which was evaluated based on migration 
times and peak areas, was excellent, and particularly in the case where the peak area of the 
internal standard was also taken into consideration. The LOD and the LOQ were 
determined based on the standard deviation of the peak area and the slope of the calibration 
curve. The LOD and the LOQ were calculated as 3 and 10 times the above correlation, 
respectively. In the plasma sample, the LOD and the LOQ were found to be 2.8 ng/mL and 
8.4 ng/mL, respectively, while in standard solutions they were 1.6 ng/mL and 5.0 ng/mL, 
respectively. These values are considered satisfactory for the accurate and precise 
quantification of rivastigmine in AD patients treated with the particular drug compound, 
and this is based on clinical studies that were performed in such patients [38,39]. 
3.3. Application 
Biological matrices are among the most difficult samples to analyze because of the big 
number of components they contain that they may be adsorbed onto the capillary wall or 
interfere in the detection and/or separation process. Therefore, before plasma analysis, it is 
important and necessary to perform a sample preparation procedure. In addition to this, the 
concentration of most of the analytes in biological samples is low; so, a preconcentration 
step before the detection and quantitation is required. In many cases, different sample pre-
treatment methods are used and compared in order to determine the most effective one, in 
regard to analyte recovery, difficulty, time and reproducibility. In this study, one LLE and 
two different SPE procedures were examined. In the case of SPE, two different SPE 
cartridges were used, a C18 cartridge and an Oasis HLB cartridge. LLE proved to be 
inefficient for rivastigmine assay, and it was time consuming because the extraction step 
was followed by additional steps that involved evaporation and reconstitution of the 
residue in an organic solvent. When the two SPE methods were compared, the C18-SPE 
cartridge proved to be the optimum, because the S/N was three times higher (S/N=154) than 
when Oasis HLB cartridge was used (S/N=52), and it provided better recoveries. 
The optimum CZE-ESI-MS parameters and the optimum sample preparation procedure 
were finally applied for the determination of rivastigmine in a plasma sample obtained from 
an AD patient following rivastigmine patch administration (dose of 9.5 mg/mL 
rivastigmine/24-h). Figure 7 demonstrates the SIM electropherograms of C18-SPE extract of 
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plasma sample collected 2.0 hours post-application, at m/z 223 and 251, for I.S. and 
rivastigmine, respectively. The mean (± S.D.) plasma concentration obtained for 
rivastigmine was 14.6 (± 1.7) ng/mL. 
 
Figure 7. Electropherograms of C18-SPE extracts of plasma from an AD patient following rivastigmine 
patch administration in a dose of 9.5 mg/mL / 24-h in the SIM-mode at (a) m/z 223 (I.S.) and (b) m/z 251 
(rivastigmine). Conditions: BGE: 40 mM ammonium acetate at pH 9, sheath liquid 1 % acetic acid in 
water:MeOH (50:50 v/v) at a flow rate of 10 μL/min, analyte and I.S. concentrations 0.3 mg/mL. Drying 
gas flow rate 6 L/min and temperature 200 ºC, nebulizer gas pressure 20 psi [24]. 
Based on the studies mentioned above, the CZE-ESI-MS method proved to be a promising 
technique in drug and pharmaceutical analysis. The development of such a method has 
several advantages over HPLC-MS and GC-MS. The most important ones are the reduction 
of the reagents cost, the low injection volume requirements, and the avoidance of disposing 
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large volumes of organic waste. In particular, when the study described here is compared to 
previous studies, where HPLC-MS and GC-MS were used for the analysis of rivastigmine, 
the required injection volume of plasma for a single analysis is reduced from microliters [40-
43] to nanoliters. 
4. Determination of enantiomers in pharmaceutical samples 
In the last three decades, there has been a growing interest in the separation, detection and 
quantification of enantiomers in pharmaceutical, clinical, environmental and food analysis. 
It has been known that usually only one enantiomer is active while the other may be less 
active, inactive or has adverse effects. Among the separation techniques, HPLC [44-48] GC 
[44,45,49] and CE [50-55] are most often applied in chiral analysis. Temperature and 
derivatization are major problems encountered in GC, and poor separation efficiency is 
observed in HPLC. CE has proven to be a powerful separation technique in the area of chiral 
analysis, since it has the major advantage of low consumption of samples and solvents. 
The most common modes of chiral CE are electrokinetic chromatography (EKC) in the 
presence of a chiral selector, MEKC, capillary electrochromatography (CEC), where the chiral 
selector can be either used as a coating (OT-CEC), a packing (P-CEC) or a monolithic material 
(M-CEC) in the capillary, and others [55-63]. The prerequisite for separation of enantiomers in 
CE, as in every chromatographic system, is the formation of either stable diastereoisomers by 
the use of a chiral derivatization agent or reversible diastereoisomeric complexes with the 
addition of a chiral substance, (chiral selector). In the first case, the two enantiomers are 
separated based on their different physicochemical properties, while in the second case, they 
are separated based on their different mobilities. In general, the “three point rule,” illustrated 
by Easson and Stedman [64], describes the interactions that are necessary for chiral 
discrimination. A minimum of three simultaneous interactions have to occur between the 
chiral selector and one of the enantiomers so that chiral separation is achieved. The other 
enantiomer, due to spatial restrictions, should have at least two types of interactions, which 
can be hydrophobic interactions between the hydrophobic core of the polymer and the analyte, 
electrostatic interactions between the polar head group of the polymer and the analyte, dipole-
dipole forces, such as hydrogen bonding between the polar group of the chiral selector and the 
analyte, and secondary interactions, such as - interactions, ion-dipole bonds, and Van der 
Waals forces. This difference in the number and type of interactions between the enantiomers 
and the chiral selector generates a mobility difference between the enantiomer-chiral selector 
complexes, which is necessary for the achievement of a chiral separation. 
A big number of chiral selectors have been widely used, over the years, in CE for improved 
chiral separations of various classes of analytes. These chiral selectors include cyclodextrins, 
polymeric surfactants, cyclofructans, macrocyclic antibiotics, crown ethers, and others. 
Cyclodextrins are molecules with large ring-like structures composed of α-(1,4)-linked D-
(+)-glucopyranose units. Native cyclodextrins are cyclic oligosaccharides consisting of six (α-
CD), seven (β-CD) and eight (γ-CD) glucopyranose units. The chiral recognition ability of 
cyclodextrins can be improved by their derivatization with different functional groups, such 
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as methyl-, sulfate-, acetyl- and prolyl-, and with the modification of the hydroxyl groups, 
which are present on the rim of the CD. The mechanism of enantiomeric discrimination is 
the inclusion of the hydrophobic group of the analyte into the cavity and interactions of the 
hydroxyl groups of the C2 and C3 at the upper rim of the CD, such as hydrogen bonds and 
dipole-dipole interactions. 
Navarro et al. [65] developed a CZE method for the analysis of lansoprazole enantiomers in 
three different pharmaceutical preparations (Davur, Alter and Cinfa). β-CD was used as a 
chiral selector and sodium sulphite was used as an additive. Recoveries of 91-102% of the 
label content were obtained, and this demonstrated the potential of the method for the 
routine quality control of lansoprazole enantiomers in pharmaceutical formulations. 
Chai et al. [66] used the chiral selector hydroxypropyl-γ-cyclodextrin in order to separate the 
antifungal drug iodiconazole and the structurally related triadimenol analogues. This chiral 
selector provided the best results in regard to resolution due to its large cavity and the 
hydrogen bonding between the analytes and the cyclodextrin. The mechanism for the chiral 
discrimination of hydroxypropyl cyclodextrins possibly involves the development of 
secondary interactions between the chiral analyte and the hydroxypropyl groups on the 
cyclodextrin rim after the inclusion of the analyte into the cavity. The degree of substitution 
and the type of the hydroxyalkyl group on the cyclodextrin rim, which influences the depth 
of the cavity, can therefore change the enantiorecognition ability of the cyclodextrin [67,68]. 
4.1. Method development and validation 
The use of CE, and particularly MEKC, in chiral analysis is demonstrated further here by 
providing a more in-depth analysis of a research work that was performed in a pharmaceutical 
formulation that contained one of the enantiomers of Huperzine A [55]. Huperzine A is 
considered to be a potent, highly specific and reversible inhibitor of acetylcholinesterase with 
high efficiency and low toxicity. The mechanism of complexation of Huperzine A with 
acetylcholinesterase is similar to that of other pharmaceutical drugs that are used for the 
treatment of AD [69]. The (-)-enantiomer of Huperzine A is three times more biologically 
active than the synthetically racemic mixture, and only this form behaves as a potential 
acetylcholinesterase inhibitor. Therefore, the development of an analytical method for the 
enantiomeric separation of the synthetic Huperzine A is of greatest importance. 
It is important here to mention that the type of the chiral selector used in this study was the 
polymeric surfactant. The use of polymeric surfactants in both chiral and achiral CE has 
attracted considerable attention. In 1994, Wang and Warner [70] were the first to report the 
use of a polymeric surfactant added to the BGE in MEKC. Polymeric surfactants offer 
several distinct advantages over conventional micelles [63,71-73]. Firstly, polymerization of 
the surfactant eliminates the dynamic equilibrium due to the formation of covalent bonds 
between the surfactant aggregates. This, in turn, enhances stability and improves resolution. 
Secondly, polymeric surfactants can be used at low concentrations because they do not 
depend on the CMC. This usually provides higher efficiencies and rapid analysis. They 
have, over the years, been extensively used in a BGE [74-80], in a polyelectrolyte multilayer 
coating [63,74,81-83], and in a CE-MS system [84-86]. 
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In this study, the optimal conditions, in regard to resolution, efficiency and analysis time, 
were initially established by varying different electrophoretic parameters. The BGE type, 
concentration and pH are usually the first parameters to be examined in a method 
development procedure. Sodium acetate at acidic and neutral pHs, where the analyte 
exhibits cationic behavior, was chosen as the optimum. BGEs with basic pHs did not exhibit 
any enantiomeric discrimination, and the analysis time was very long. The optimum pH 
was 5.0 because it provided slightly better peak shapes, and the optimum concentration was 
50 mM because it provided higher resolution (Figure 8). The very low peak efficiency, which 
needs to be improved, is clearly illustrated in this figure. 
 
 
 
 
Figure 8. Effect of BGE concentration on the separation of the enantiomers of Huperzine A: (A) 20 mM, 
(B) 35 mM and (C) 50 mM. Separation conditions: BGE: sodium acetate (pH 5.0), 0.075% (w/v) poly-LL-
SULV; pressure injection, 30 mbar for 3 s; applied voltage, 20 kV; temperature, 25 °C; fused-silica 
capillary, 64 cm (55.5 cm effective length) x 50 μm i.d.; detection, 230 nm [55]. 
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As far as the chiral selector is concerned, different polymeric surfactants were examined, 
such as poly(sodium N-undecanoyl-L-leucinate) (poly-L-SUL), poly(sodium N-undecanoyl-
LL-leucyl-leucinate) (poly-LL-SULL), poly(sodium N-undecanoyl-LL-leucyl-valinate) (poly-
LL-SULV), poly(sodium N-undecanoyl-L-valinate) (poly-L-SUV), poly(sodium N-
undecanoyl-L-valyl-glycinate) (poly-L-SUVG), poly(sodium N-undecanoyl-LL-alanyl-
valinate) (poly-LL-SUAV), poly(sodium N-undecanoyl-LL-leucyl-alanate) (poly-LL-SULA), 
and poly(sodium N-undecanoyl-LL-valyl-valinate) (poly-LL-SUVV). The polymeric 
surfacant poly-LL-SULV, which has shown the best chiral discrimination ability for a 
number of pharmaceutical compounds [80], was the first to be examined in different 
concentrations. The concentration of 0.075% w/v was chosen as the optimum, based on 
analysis time, efficiency and resolution. This concentration though did not provide baseline 
resolution. 
Another parameter examined in order to improve peak efficiency and resolution was the 
addition of modifiers. None of the organic solvents at different concentrations were able to 
improve the separation. An alternative to this was the addition of a salt, such as D- and L-
alanine tert-butyl ester hydrochloride (D- and L-AlaC4Cl). poly-LL-SULV became insoluble 
when the salt was added into the BGE. Therefore, the other polymeric surfactants 
mentioned above were examined at different concentrations. In each case, D- and L-AlaC4Cl 
were used individually as additives, the electropherograms were obtained, and resolution 
and efficiency were estimated. Based on this, the combination of poly-LL-SUAV at a 
concentration of 0.20% (w/v) with L-AlaC4Cl provided the best results. 
However, the use of L-AlaC4Cl did not provide satisfactory reproducibility of the migration 
time and efficiency. This is probably due to the hydrolysis of the salt in an aqueous BGE 
solution. An alternative involved the use of tert-butanol, one of the hydrolysis products, at 
different concentrations. Figure 9 clearly demonstrates the improved peak efficiency, in 
comparison with Figure 8. Each electropherogram was obtained at a different concentration 
of tert-butanol. A concentration of 10% (v/v) was the optimum, because it provided the 
highest resolution (1.45) and the highest peak efficiency (Figure 10). 
The validation of the method demonstrated good linearities and very low relative standard 
deviation values, indicating excellent run-to-run and day-to-day reproducibilities. In addition, 
the LOD and LOQ were determined to be 4.17 μg/mL and 13.92 μg/mL, respectively. 
4.2. Application 
As previously shown, after method development and validation, the optimum separation 
conditions are applied to a real sample. In this case, the optimum parameters were applied 
to a pharmaceutical formulation in order to detect and quantitate the acetylcholinesterase 
inhibitor (-)-Huperzine A. The extraction procedure followed for extracting Huperzine A 
from the pharmaceutical formulation proved to be effective because the enantiomer 
determined in the sample was in a relatively good agreement with the amount that was 
stated on the bottle. Therefore, the developed MEKC-UV method is able to control the 
purity of (-)-Huperzine A in pharmaceutical formulations. 
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Figure 9. Effect of the concentration of tert-butanol on the separation of the enantiomers of Huperzine 
A: (A) 5%, (B) 7.5%, (C) 10% and (D) 12% (v/v). Separation conditions: BGE: 50 mM sodium acetate (pH 
5.0), 0.2% (w/v) poly-LL-SUAV; pressure injection, 30 mbar for 3 s; applied voltage, 20 kV; temperature, 
25 °C; fused-silica capillary, 64 cm (55.5 cm effective length) x 50 μm i.d.; detection, 230 nm [55]. 
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Figure 10. Effect of the concentration of tert-butanol on the efficiency. Separation conditions: Same as 
Fig. 4. BGE: 50 mM sodium acetate (pH 5.0), 0.2% (w/v) poly-LL-SUAV; pressure injection, 30 mbar for 3 
s; applied voltage, 20 kV; temperature, 25 °C; fused-silica capillary, 64 cm (55.5 cm effective length) x 50 
μm i.d.; detection, 230 nm [55]. 
5. Concluding remarks 
Analysis of chiral and achiral analytes in natural, pharmaceutical and biological samples can 
be extremely difficult. Co-migration may occur, which can cause problems in detection, and 
the electropherograms obtained can be very complex. In addition, the analytes of interest are 
usually present in the matrices at very low concentrations. Therefore, all the analytical steps, 
including method development, detection and sample preparation, which is an essential 
stage in any analysis process, have to be optimized in order to obtain the desirable 
sensitivity, resolution, robustness and analysis time. 
Among the separation techniques that have so far been used for pharmaceutical, clinical and 
food analysis, CE has been established as a powerful analytical tool, which has rapidly been 
developed and matured since its introduction. CE and its related techniques offer a number 
of advantages, including low consumption of sample and solvents, high separation 
efficiency, rapid method development, fast migration times, versatility, and simple 
instrumentation. Another important aspect involves its ability to separate small and large 
molecules, charged and neutral species, inorganic and organic molecules, synthetic and 
natural compounds, along with proteins and peptides. 
The coupling of CE to MS provides nowadays a promising alternative to UV detection. The 
combination of high sensitivity, high selectivity, and high specificity provided by MS with 
high resolution, and high efficiency provided by CE makes it an attractive technique in 
different fields, such as clinical, forensic, pharmaceutical, and others. However, chiral 
analysis by use of CE-MS still needs some improvement, in regard to resolution and peak 
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capacity. In addition, contamination of the ionization source induced by the chiral selector 
added in the BGE is still considered a main problem, even though different procedures 
have, in recent years, been developed in order to overcome this limitation [87]. 
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